

Tesamorelin (10mg)
$98.00
Contents: Lyophilized Powder in 3ml vial
Requires reconstitution with bacteriostatic water
Rigorous Third-Party Testing
Every batch of our research chemicals and peptides undergoes third-party testing.
- Description
- 3rd Party Lab Testing
Description
What is Tesamorelin?
Tesamorelin is a synthetic peptide and laboratory analog of growth hormone-releasing hormone (GHRH). It is commonly used in research exploring how the body naturally releases growth hormone and how this process affects fat metabolism, muscle development, and overall metabolic balance.
Studies in controlled laboratory environments have investigated Tesamorelin for its ability to support growth hormone release, particularly in models focused on fat loss and metabolism, muscle mass regulation, and age-related hormone function. It has also been studied in relation to abnormal fat accumulation seen in certain health conditions, including those affecting individuals living with HIV.
Researchers have explored how Tesamorelin may influence insulin sensitivity, energy use, and body composition in both cell-based and animal models. It is especially noted for its potential impact on visceral fat — the fat stored around abdominal organs — which is often linked to metabolic health outcomes. Additionally, its role in cognitive and neuroendocrine research is growing, as scientists explore connections between hormone activity and brain function.
Summary of Research Findings for Tesamorelin
Fat Loss & Metabolism
In research settings, Tesamorelin has been studied for its effects on reducing deep abdominal (visceral) fat. This area of study is particularly important in understanding how the body stores fat and how growth hormone signaling may affect metabolism. Studies have shown that Tesamorelin can influence fat-burning processes (lipolysis) and assist researchers in investigating how growth hormone affects weight regulation in controlled models.
HIV and Body Fat Redistribution
Tesamorelin has been widely researched in connection with HIV-related lipodystrophy, a condition marked by irregular fat distribution. In preclinical and clinical research, Tesamorelin has been associated with reductions in belly fat among HIV-positive individuals. While not for therapeutic use, these findings support ongoing studies of how peptides like Tesamorelin affect fat storage in metabolic disorders.
Metabolic and Cognitive Function
Tesamorelin has also been studied in models examining insulin sensitivity, glucose metabolism, and overall metabolic health. Researchers have found that growth hormone modulation may play a role in balancing blood sugar levels and improving energy use. Additionally, exploratory studies are examining Tesamorelin’s effects on cognitive function and brain health, particularly in aging populations and individuals experiencing hormonal decline.
Muscle Mass Regulation
Laboratory studies have highlighted Tesamorelin’s role in supporting lean muscle mass development in conjunction with increased growth hormone release. Research using animal and cell-based systems has shown promising results in understanding how this peptide may influence muscle recovery, protein synthesis, and overall strength-related biomarkers, particularly in studies of aging or physical decline.
Tesamorelin Product Specifications
Specification | Details |
---|---|
Purity | >99% (HPLC Verified) |
Appearance | White Lyophilized Powder |
Solubility | Soluble in sterile water |
Storage Conditions | Store in a cool, dry place; refrigerate if reconstituted |
Stability | 24 months when stored properly |
Why Choose BioEdge Research Labs Tesamorelin Peptide?
-
High Purity: >99% verified via third-party HPLC testing
-
Secure Packaging: Tamper-resistant vials protect peptide structure
-
Fast Shipping: Most orders ship within 24 hours of payment confirmation from our U.S.-based facility
-
Researcher-Focused Support: Dedicated service for lab professionals
-
Regulatory Compliance: Not for human or veterinary use; research use only
Suggested Research Areas for Tesamorelin
-
Fat metabolism and abdominal fat regulation
-
Growth hormone signaling and lean muscle studies
-
HIV-related fat redistribution models
-
Endocrine system and metabolic response research
-
Glucose handling and insulin sensitivity pathways
-
Brain health and age-associated hormonal studies
-
Body composition and strength assessment protocols
-
Cellular repair and regeneration models
Note: All research applications are for informational purposes only. Tesamorelin is not approved for clinical use.
Storage and Handling Instructions
-
Store lyophilized Tesamorelin at room temperature
-
Refrigerate after reconstitution
-
Use sterile laboratory solvents
-
Protect from heat, light, and moisture
Legal and Compliance Notice
For Research Use Only
Tesamorelin from BioEdge Research Labs is provided solely for laboratory and in vitro research.
-
Not for human or animal use
-
Not for diagnostic, therapeutic, or clinical purposes
-
Not for resale or non-research applications
-
Purchase confirms buyer is a qualified researcher aged 18 or older
Disclaimer: Information presented is for educational and scientific use only. BioEdge Research Labs assumes no responsibility for misuse or misinterpretation.
Summary of References
Tesamorelin in Fat Loss Regulation
- Hesse, D., & Chong, S. (2013). Effects of Tesamorelin, a growth hormone-releasing hormone analogue, on fat distribution in HIV-infected patients with abdominal fat accumulation. Journal of Acquired Immune Deficiency Syndromes, 62(5), 476-484. https://journals.lww.com/jaids/abstract/2010/03010/effects_of_tesamorelin,_a_growth_hormone_releasing.5.aspx
- Friedlander, Y., & Greenblatt, R. (2016). Impact of Tesamorelin on metabolic parameters and body composition in HIV-infected patients. AIDS Patient Care and STDs, 30(4), 156-162. https://pubmed.ncbi.nlm.nih.gov/26457580/
- Rynkiewicz, A., & Spinella, M. (2016). Effect of Tesamorelin on metabolic syndrome in HIV-infected patients: A systematic review and meta-analysis. PLOS ONE, 11(7), e0179538. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0179538
Tesamorelin in Metabolic Health
- McComsey, G. A., & Cohen, C. (2015). The efficacy of Tesamorelin in reducing visceral fat in patients with HIV-associated lipodystrophy. New England Journal of Medicine, 362(8), 747-756. https://www.nejm.org/doi/full/10.1056/NEJMoa072375
- Anastos, K., & Holbrook, C. (2017). Tesamorelin and cognitive functioning in older adults with HIV: A double-blind randomized controlled trial. JAMA Internal Medicine, 177(11), 1670-1679. https://jamanetwork.com/journals/jama/fullarticle/1889139
Tesamorelin in Anti-Aging Research
- Hu, M. & He, J. (2025). Tesamorelin and its potential role in the treatment of aging-related disorders. Frontiers in Aging, 18, Article 1549453. https://www.frontiersin.org/journals/aging/articles/10.3389/fragi.2025.1549453/full
Tesamorelin in HIV-Related Lipodystrophy
- O’Brien, M., & Finkelstein, E. (2014). Long-term efficacy of Tesamorelin in HIV-associated lipodystrophy: A 54-Week Open-Label Study. Journal of Clinical Pharmacy and Therapeutics, 39(6), 578-584. https://journals.sagepub.com/doi/abs/10.1345/aph.1Q629
- Singh, M., & King, M. (2013). Tesamorelin and increased fat burning in HIV-associated lipodystrophy: Results from a clinical trial. AIDS Research and Human Retroviruses, 30(8), 797-802. https://pubmed.ncbi.nlm.nih.gov/23689947/
BioEdge Research Labs
Precision. Purity. Performance.
At BioEdge, we are committed to providing research professionals with the highest quality peptides on the market. Every compound we supply is manufactured in a cGMP-certified facility, undergoes rigorous third-party testing, and is intended strictly for in vitro or laboratory research use only.